*The following content is generated by AI and is for reference only.
Overview
Palbociclib (CAS 571675-40-2) is a selective CDK4/6 inhibitor with molecular formula C26H33N7O3. It is synthesized via advanced organic coupling processes for pharmaceutical grade production.
Application
- Manufacturing of oncology APIs for breast cancer therapies.
- Supply to contract research organizations for clinical trial formulations.
- Integration into combination regimens with endocrine therapies.
Precautions
Requires strict temperature control below 25°C and humidity protection. Clinical use mandates monitoring for neutropenia and hepatic impairment in patients.